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which carries a number of technical problems but which is of interest in that it may give some indication of the excitability of the motor neurone pool in man is the study of the H reflex. In healthy subjects this reflex potential can only be obtained after stimulation of the posterior tibial nerve but in the presence of spasticity it can be more widely elicited.
The ratio of the amplitude of the H wave to that of the M wave has been used as a measure of spasticity (Angel & Hofmann 1963) but Matthews (1966) has found it of little value in assessing the value of drugs such as diazepam. Of possibly greater interest is the recovery cycle of the H reflex when it is elicited with paired stimuli. The H response to the second stimulus is in general more readily evoked in states of spasticity and in Parkinsonian rigidity (Magladery et al. 1952 , Olsen & Diamantopoulos 1967 . Two problems make this a difficult technique to apply to the assessment of drug action; first, the response is variable so that the most rigorous attention to technique is necessary; secondly, the H reflex, which is the electrical representation of the anklejerk, is subserved by a two-neurone arc so that its validity in assessing the action of drugs which act on polysynaptic pathways is uncertain.
At the present rime there is no substitute for the careful clinical assessment of spasticity. There is a need for further research both in developing further active preparations for the relief of spasticity and towards the systematic evaluation of their effects. The intrathecal injection of dilute solutions of phenol as a means of reducing spasticity has been practised for many years (Nathan 1965) , but its usefulness is limited by technical difficulties and the risks of arachnoiditis and dysfunction of the sphincters. In the past six years there have been several reports (Khalili & Betts 1967 , Halpern & Meelhuysen 1966 ) describing peripheral nerve block at various levels and motor point block with phenol in the management of spasticity.
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Initially it was claimed that the dilute phenol had a specific action on gamma efferent fibres, but it has now been shown histologically and by electromyographic methods that in fact all fibres including alpha motor fibres are involved in the neurolytic process.
Method
Both nerves and motor points are located by using the nerve stimulator in a standard Medelec electromyograph with a pulse duration of 0-1 ms and a repetition rate of 1 per second. The hypodermic needles are 22 gauge, of varying length up to 10 cm, and coated in Teflon except for the bevelled edge at the tip. The needle, which acts as the cathode, is connected to the stimulator by a lead which is clipped or soldered to the hub of the needle. The anode is connected to a dispersive electrode placed behind the limb. The nerves are approached by the usual techniques described for nerve blocks, the stimulating needle being introduced directly without local anmsthesia. The current is increased to 10 mA and the tip of the needle is slowly advanced in the direction of the nerve. Contractions in the spastic muscles are seen and, more sensitively, palpated as the tip comes close to the nerve. The current may then be reduced progressively as the nerve is approached. The tip can be assumed to be in contact with the nerve when the maximum contraction is obtained with the minimum of current. At this stage rotation of the needle may be required to reach the end-point. The smallest movement of the needle may result in a loss of contractions and we find that it is better to have one person manipulating the syringe and needle and a second person palpating the spastic muscles and adjusting the output of current. This demands good technical rapport between the operators. Meelhuysen et al. (1968) recommend the use of a minimum volume extender between the needle and the syringe to reduce the likelihood of movement of the needle during injection. After preliminary aspiration a small quantity, usually 0-1 ml, of an aqueous solution of phenol is injected. For nerve blocks we use a 3 %solution and for motor point blocks a 5 % solution of phenol. The immediate effects are the abolition of contractions and a reduction in the degree of spasticity. After locating the nerve again, more phenol is injected, 0-1 ml at a time, until the desired degree of tone is achieved. The limb very often becomes warmer and pinker immediately following the injection due to block of the sympathetic fibres. The amount of solution required will vary between 1 and 4 ml. Motor point blocks are carried out by first locating the motor point with a surface stimulator in the usual manner and then locating the points of maximum electrical sensitivity in the depths of the muscle with the coated needle electrode.
Discussion
We have now used this method in a variety of spastic conditions including hemiplegia, paraplegia, cerebral palsy and disseminated sclerosis. In hemiplegia the usual problem in the upper limb is that of a tight hand with marked spasticity of the wrist and finger flexors in which there is some active contraction of the flexors but no active extension of the fingers is possible. What grip the patient has is of little or no functional value. Phenol block of the median nerve in the upper arm will produce satisfactory relaxation in most patients; only occasionally is it necessary to block the ulnar nerve in addition. A combination of nerve and motor point block may be needed to achieve satisfactory relaxation of wrist, finger and thumb flexors in some patients. Grip strength is commonly reduced by a variable degree, but this usually increases after a few days although not always to the previous level. A few patients show an immediate increase in grip strength after the block. A small number of patients gain active extension of the fingers which was not detectable before the block, and in those with some active extension before the block both power and range are increased afterwards. Relaxation after gripping is greatly facilitated and this alone makes the hand functionally more useful. The relaxed hand is of course much more acceptable cosmetically, and is easier to manipulate and wash than the spastic hand. One patient estimated that his hand was 25 % better after the block. Our orthopxdic colleagues agree with us that tendon transfer may be facilitated by this procedure and in suitable patients we hope to use wrist flexors to provide active extension of the fingers. Shoulder clonus is sometimes a troublesome feature in hemiplegia. This may be abolished and spasticity of the elbow flexors reduced by blocking the upper trunk of the brachial plexus.
In the lower limb reduction of hamstring spasticity by means of a high sciatic block may facilitate correction of a knee flexion deformity, and the abolition of ankle clonus is one of the most striking and useful consequences of a sciatic or medial popliteal block.
In patients suffering from disseminated sclerosis adductor spasm may be relieved by obturator block, and I have one patient with spastic diplegia following a head injury in childhood whose scissors gait was corrected by obturator block. The latest extension of this technique is the blocking of lumbar spinal nerves by the paravertebral route (Meelhuysen et al. 1968 ). This effectively reduces flexor spasticity of the hip without hazard to the bladder.
According to Khalili & Betts (1967) , the duration of effect ranges from two days to two years with an average of ten months. We have now carried out 50 nerve and motor point blocks on 33 patients and our experience to date accords with this. In most patients there has been some minor return of spasticity within three or four weeks but the majority have retained a useful reduction of spasticity for up to 13 months. Electro-diagnostic studies carried out on a limited number of patients have in most cases revealed evidence of denervation and conduction abnormalities.
The disadvantages of this method are occasional local discomfort at the site of injection which usually passes off within hours, occasional transient parmsthesix and the possibility of future development of causalgia. The latter complication has not yet been reported. The dose of phenol needed to produce systemic toxic manifestations has been estimated at between 8 and 15g; 4 ml of 5 % phenol, the most we have used in one injection, contains 0-2 g. The advantages are that it is simple, safe, cheap, gives immediate results and may be repeated as necessary.
